Truist Securities Upgrades Sabra Health Care REIT to Buy, Maintains Price Target to $22

Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc.

SBRA

0.00

Truist Securities analyst Michael Lewis upgrades Sabra Health Care REIT (NASDAQ: SBRA) from Hold to Buy and maintains the price target from $22 to $22.